External fixation as definitive treatment or external fixation followed by early fixation in open fractures of the tibial shaft: A descriptive study.


Journal

Injury
ISSN: 1879-0267
Titre abrégé: Injury
Pays: Netherlands
ID NLM: 0226040

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 23 11 2023
revised: 08 02 2024
accepted: 25 02 2024
medline: 29 7 2024
pubmed: 29 7 2024
entrez: 28 7 2024
Statut: ppublish

Résumé

Treatment options for open tibial shaft fractures include external fixation with or without early conversion to internal fixation. The aim of this study was to describe 1) early conversion to internal fixation and definitive external fixation and 2) in case of conversion, to identify risk factors for complications. Seventy-two external fixations of open fractures of the tibial shaft (Gustilo classification, 7 fractures (9.7 %) grade I, 25 fractures (34.7 %) grade II, 40 fractures (55.6 %) grade III (31 grade IIIA and 9 grade IIIB)) were included in a continuous non-randomised study. Thirty-three fractures without infection signs were converted to internal fixation at a mean time of 40.5 +/-15 days (IF group). External fixation was maintened in the remaining 39 fractures (EF group). In the "IF" group, the union rate was 69.7 % at 6.3 +/-3.6 months (3-16). All patients had complete union at 16 months, requiring 2.8 +/-0.8 reoperations. Fixation with external fixation only ("EF" group) showed a union rate of 51.3 % at 8.9 +/-4 (5-22) months and 96 % at 16 months after 3.7 +/-0.9 reoperations. Superficial infection (12.1 %; p = 0.011) and numerous surgeries (2.76; p = 0.004) were found to be risk factors for deep infection. Time to wound closure >7 days (p = 0.049), time to reoperation >28 days (p = 0.00), numerous surgeries (2.76; p = 0.004) and deep infection (6.1 %; p = 0.027) were found to be union failure factors. Early conversion of external fixation to internal fixation is an effective option to achieve bone union of open tibial fractures in selected patients.

Identifiants

pubmed: 39069345
pii: S0020-1383(24)00164-5
doi: 10.1016/j.injury.2024.111477
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111477

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest Marie Le Baron: no conflict of interest, Pascal Maman: consultant for Newclip, Richard Volpi: no conflict of interest, Xavier Flecher: consultant for Zimmer and Stryker endoscopy

Auteurs

Marie Le Baron (M)

Centre de Chirurgie orthopédique et traumatologie, Centre Hospitalo-Universitaire Nord, Marseille, Hôpital Nord, Chemin des Bourrely, 13915, Marseille, France. Electronic address: marie.lebaron@ap-hm.fr.

Pascal Maman (P)

Centre de Chirurgie orthopédique et traumatologie, Centre Hospitalo-Universitaire Nord, Marseille, Hôpital Nord, Chemin des Bourrely, 13915, Marseille, France.

Richard Volpi (R)

Centre de Chirurgie orthopédique et traumatologie, Centre Hospitalo-Universitaire Nord, Marseille, Hôpital Nord, Chemin des Bourrely, 13915, Marseille, France.

Xavier Flecher (X)

Centre de Chirurgie orthopédique et traumatologie, Centre Hospitalo-Universitaire Nord, Marseille, Hôpital Nord, Chemin des Bourrely, 13915, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH